Clinical Trials Logo
  1. Home
  2. Solid Organ Transplant
  3. NCT00907023
  4. Details
NCT00907023 Clinical Trial

Transition From Hospital to Home in Solid Organ Transplant (SOT)

Solid Organ Transplant Clinical Trial

Official title:
The Transition From Hospital to Home in Parents of Solid Organ Transplant Recipients

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00907023
Other study ID # CHW 09/10
Secondary ID GC 811
Status Completed
Phase N/A
First received May 20, 2009
Last updated November 8, 2011
Start date January 2009
Est. completion date May 2011

Study information
Verified date November 2011
Source Medical College of Wisconsin
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The aim of this study is to determine the influences of discharge teaching and care coordination on how ready a parent is to take their child home from the hospital after a solid organ (kidney, heart and liver) transplant. This study will also look into how the parent handles coping, utilization of healthcare resources, and parent adjustment 3 weeks after discharge from the hospital.

Description:

Parents of children that have received a heart, kidney or liver transplant will be asked to participate in this protocol. Involvement in this study involves completion of questionnaires prior to the child being discharged from the hospital. Three weeks after discharge, there will also be a follow-up phone call to complete more questionnaires.

Readiness for hospital discharge is a under-investigated topic in pediatric solid organ transplant patients, despite the increasing number of pediatric patients undergoing transplant surgery. Results from this study will be used to develop an intervention program to promote readiness for hospital discharge in parents of children who receive a solid organ transplant.

Recruitment information / eligibility
Status Completed
Enrollment 37
Est. completion date May 2011
Est. primary completion date May 2010
Accepts healthy volunteers No
Gender Both
Age group N/A to 18 Years
Eligibility Inclusion Criteria:

- parents of children who have undergo a heart, kidney, or liver transplant

- English Speaking

- Parents are 18 years of age or older

Exclusion Criteria:

- parents with significant cognitive or communication impairment that would not allow them to complete the questionnaires

- parent whose child is receiving their 2nd or 3rd organ transplant

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
United States Levine Children's Hospital Charlotte North Carolina
United States Children's Memorial Hospital Chicago Illinois
United States Children's Hospital of Wisconsin Milwaukee Wisconsin

Sponsors (1)
Lead Sponsor Collaborator
Medical College of Wisconsin

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Determine the influences of care coordination and discharge teaching on readiness for discharge in solid organ transplant recipients 2 years No
Secondary Determine the relationship of parent readiness for hospital discharge with coping, utilization of healthcare resources, medication adherence, and parent adjustment following hospital discharge 2 years No
See also
  Status Clinical Trial Phase
Terminated NCT03950414 - A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients Phase 1
Recruiting NCT05663463 - Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients N/A
Completed NCT05124509 - Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
Completed NCT05121142 - Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease Phase 1
Completed NCT01058239 - Bortezomib Plus Rituximab for EBV+ PTLD Phase 2
Withdrawn NCT03327987 - Early Flu Shots in SOT
Completed NCT04253548 - iPeer2Peer Pediatric Thoracic Transplantation N/A
Recruiting NCT05164016 - Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
Withdrawn NCT02464306 - Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection Phase 4
Completed NCT02165423 - Discharge to Home and Chronic Illness Care Pilot N/A
Recruiting NCT04613206 - High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients Phase 2
Recruiting NCT05550298 - Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Completed NCT00518778 - Fusariosis in Solid-Organ Transplant Recipients N/A
Active, not recruiting NCT04331275 - Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant Phase 2
Recruiting NCT05968807 - iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients N/A
Active, not recruiting NCT03482739 - Safety, Tolerability and Immunogenicity of a Nine-valent Human Papillomavirus (HPV) Vaccine in HIV and Transplant Patients Phase 3
Not yet recruiting NCT04721288 - REmote moBile Outpatient mOnitoring in Transplant 2.0 N/A
Completed NCT04844489 - Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People N/A
Active, not recruiting NCT03360682 - Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV‐1‐Infected Solid Organ Transplant Patients Phase 4